ATP-competitive inhibitors for cancer treatment – kinases and the world beyond
RSC Medicinal Chemistry · 2025 · 16 (9) · 4044-4067
DOI: 10.1039/d5md00235d ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Ana Jug und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Ljubljana, Faculty of Pharmacy Ljubljana Slovenia janez.ilas@ffa.uni-lj.si. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: The Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
This review offers a detailed examination of small-molecule ATP-competitive inhibitors, placing particular emphasis on their role in targeting non-kinase proteins involved in the initiation and progression of cancer.
Autor:innen und Institutionen
- University of Ljubljana, Faculty of Pharmacy Ljubljana Slovenia janez.ilas@ffa.uni-lj.si.
ORCID-Profile: Ana Jug, Janez Ilaš
Förderung
- The Slovenian Research and Innovation Agency
Zitieren
APA
Jug, A., & Ilaš, J. (2025). ATP-competitive inhibitors for cancer treatment – kinases and the world beyond. RSC Medicinal Chemistry, 16(9), 4044-4067. https://doi.org/10.1039/d5md00235d
Vancouver
Jug A, Ilaš J. ATP-competitive inhibitors for cancer treatment – kinases and the world beyond. RSC Medicinal Chemistry. 2025;16(9):4044-4067. doi:10.1039/d5md00235d
BibTeX
@article{Jug2025,
author = {Jug, Ana and Ilaš, Janez},
title = {ATP-competitive inhibitors for cancer treatment – kinases and the world beyond},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {9},
pages = {4044--4067},
doi = {10.1039/d5md00235d}
}
EUVIMED